Loading...
An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis
Author
Lekamwasam, S.
Adachi, Jonathan D.
Agnusdei, D.
Bilezikian, J P.
Boonen, S.
Borgström, F.
Cooper, Cyrus
Perez, A. Diez
Eastell, Richard
Hofbauer, L. C.
Kanis, John A.
Langdahl, B. L.
Lesnyak, Olga
Lorenc, R. S.
McCloskey, Eugene
Messina, O. D.
Napoli, N.
Obermayer-Pietsch, B.
Ralston, Stuart H.
Sambrook, Philip N.
Silverman, S.
Sosa, M.
Stepan, Jan J.
Suppan, G.
Wahl, D. A.
Compston, Juliet E.
Adachi, Jonathan D.
Agnusdei, D.
Bilezikian, J P.
Boonen, S.
Borgström, F.
Cooper, Cyrus
Perez, A. Diez
Eastell, Richard
Hofbauer, L. C.
Kanis, John A.
Langdahl, B. L.
Lesnyak, Olga
Lorenc, R. S.
McCloskey, Eugene
Messina, O. D.
Napoli, N.
Obermayer-Pietsch, B.
Ralston, Stuart H.
Sambrook, Philip N.
Silverman, S.
Sosa, M.
Stepan, Jan J.
Suppan, G.
Wahl, D. A.
Compston, Juliet E.
Principal Supervisor
Co-Supervisor
Degree Name
Abstract
The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
Keywords
Glucocorticoids, bone mineral density, fracture, FRAX, bone protective therapy
Publication Date
2012
Type
Journal article
Published In
Archives of Osteoporosis
Volume
7
Issue
2017-02-01
Article Number
Start page
End page
Page Range
25-30
ACU Organisational Area
Mary MacKillop Institute for Health Research
Faculty of Health Sciences
Faculty of Health Sciences
Collections
ACU Research Bank Link
Related
Open Access Status
File Access
Controlled
